Telescope Innovations Corp. Share Price

Equities

TELI

CA87953P1080

Diversified Chemicals

Market Closed - Canadian Securities Exchange 01:18:16 27/04/2024 am IST 5-day change 1st Jan Change
0.35 CAD 0.00% Intraday chart for Telescope Innovations Corp. +25.00% +45.83%

Financials

Sales 2022 0.6 0.81 49.64 Sales 2023 2.82 3.86 235.46 Capitalization 13.68M 18.71M 1.14B
Net income 2022 -5M -6.83M -417M Net income 2023 - 0 0 EV / Sales 2022 2,00,95,608 x
Net cash position 2022 719K 983K 59.99M Net cash position 2023 357K 488K 29.75M EV / Sales 2023 47,19,499 x
P/E ratio 2022
-2.19 x
P/E ratio 2023
-18.7 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 77.62%
More Fundamentals * Assessed data
Dynamic Chart
1 week+25.00%
Current month-1.41%
1 month+1.45%
3 months-5.41%
6 months+59.09%
Current year+45.83%
More quotes
1 week
0.29
Extreme 0.285
0.38
1 month
0.28
Extreme 0.28
0.38
Current year
0.21
Extreme 0.21
0.45
1 year
0.13
Extreme 0.13
0.45
3 years
0.00
Extreme 0
1.18
5 years
0.00
Extreme 0
1.18
10 years
0.00
Extreme 0
1.18
More quotes
Managers TitleAgeSince
Chief Executive Officer - 28/22/28
Director of Finance/CFO - 15/02
Chief Operating Officer - 06/22/06
Members of the board TitleAgeSince
Director/Board Member 61 27/21/27
Director/Board Member 53 27/21/27
Director/Board Member 51 31/21/31
More insiders
Date Price Change Volume
26/24/26 0.35 0.00% 33,000
25/24/25 0.35 0.00% 27,550
24/24/24 0.35 +1.45% 27,500
23/24/23 0.345 +2.99% 7,000
22/24/22 0.335 +19.64% 79,460

Delayed Quote Canadian Securities Exchange, April 27, 2024 at 01:18 am IST

More quotes
Telescope Innovations Corp. is a Canada-based chemical technology company. The Company is developing scalable manufacturing processes and tools for the pharmaceutical and chemical industries. The Company builds and deploys new enabling technologies, including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Its core technology also enables the discovery of novel molecules of therapeutics. Its suite of analytical and automation technologies, including the Direct Inject Liquid Chromatography (DILC) platform for quantitative, online reaction monitoring. DILC is a hardware and software ecosystem that enables direct sampling and analysis of chemical reactions. DILC enables unattended sample capture, quenching, dilution, and analysis using a variety of industry standard CDS platforms, including Agilent OpenLab, Agilent ChemStation, Waters Empower 3, and Shimadzu LabSolutions.
More about the company